Endpoints News Jan 26, 2026 Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing
Endpoints News Jan 24, 2026 First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more
Endpoints News Jan 23, 2026 Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster
Endpoints News Jan 23, 2026 Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO
Endpoints News Jan 22, 2026 High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’